Results 21 to 30 of about 202,243 (244)

Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?

PLoS ONE, 2018
The aim of the present study is to check whether we can replicate, in an independent series, previous results showing that the molecular study of pituitary-specific gene expression complements the inmunohistochemical identification of pituitary ...
Araceli García-Martínez, Johana Sottile, Carmen Fajardo, Pedro Riesgo, Rosa Cámara, Juan Antonio Simal, Cristina Lamas, Hernán Sandoval, Ignacio Aranda, Antonio Picó   +9 more
doaj   +1 more source

The concurrent occurrence of neuroendocrine tumour and gastrointestinal stromal tumours [PDF]

Journal of Krishna Institute of Medical Sciences University, 2022
Gastrointestinal neuroendocrine tumours are hypothesised to arise from cells in the gastrointestinal tract's diffuse neuroendocrine system. The occurrence of Gastrointestinal Stromal Tumours (GIST) along with other primary gastrointestinal malignancies ...
Divya Rathod , Samarth Shukla, Sourya Acharya, Sunita Vagha   +3 more
doaj  

The novel mTOR inhibitor RAD001 (Everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells [PDF]

, 2007
Background/Aim: Tumors exhibiting constitutively activated PI(3) K/Akt/mTOR signaling are hypersensitive to mTOR inhibitors such as RAD001 (everolimus) which is presently being investigated in clinical phase II trials in various tumor entities, including
Brand, Stephan, Göke, Burkhard, Spoettl, Gerald, De Toni, Enrico N., Meyer, Heinrich H. D., Meinecke, Jennifer, Zitzmann, Kathrin, Auernhammer, Christoph J., Zitzmann, Kathrin;De Toni, Enrico N.;Brand, Stephan;Göke, Burkhard;Meinecke, Jennifer;Spöttl, Gerald;Meyer, Heinrich H.D.;Auernhammer, Christoph J.   +8 more
core   +1 more source

Proliferation Marker (Ki67) in Sub-Categorization of Neuroendocrine Tumours of the Lung

Türk Patoloji Dergisi, 2019
Objective: The 2015 WHO classification classifies neuroendocrine tumours (NET) of the lung into typical carcinoid, atypical carcinoid, large cell neuroendocrine carcinoma and small cell carcinoma based on morphology alone.
Rashi GARG, Amanjit BAL, Ashim DAS, Navneet SINGH, Harkant SINGH   +4 more
doaj   +1 more source

Pancreatic neuroendocrine tumours in patients with von Hippel-Lindau disease

Endokrynologia Polska, 2020
Von Hippel-Lindau disease is a highly penetrant autosomal genetic disorder caused by a germline mutation in the tumour suppressor gene, manifesting with the formation of various tumours, including neuroendocrine tumours of the pancreas.
Agnieszka Zwolak, Joanna Świrska, Ewa Tywanek, Marta Dudzińska, Jerzy S. Tarach, Beata Matyjaszek-Matuszek   +5 more
doaj   +1 more source

Requiem for the Term ‘Carcinoid Tumour’ in the Gastrointestinal Tract?

Canadian Journal of Gastroenterology, 2008
Use of the term ‘carcinoid tumour’ to describe a unique type of tumour in the gastroenteropancreatic system is endemic in the medical literature and in daily clinical and pathological parlance.
Runjan Chetty
doaj   +1 more source

Gastric Mixed Adenoneuroendocrine Carcinoma with a Trilineage Cell Differentiation: Case Report and Review of the Literature

Case Reports in Oncology, 2012
Most gastric neuroendocrine tumours are well differentiated and considered as neuroendocrine neoplasms, whilst poorly differentiated lesions are considered as neuroendocrine carcinomas and account for only 6–16% of gastric neuroendocrine tumours. Gastric
Marinos Pericleous, Christos Toumpanakis, Heather Lumgair, Martyn E. Caplin, Luke Morgan-Rowe, Ian Clark, Tu Vinh Luong   +6 more
doaj   +1 more source

THERANOSTICS- NEUROENDOCRINE TUMOURS

Journal of Cancer and Allied Specialties, 2018
-
Muhammad Numair Younis, Humayun Bashir
doaj   +1 more source

Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours. [PDF]

, 2022
BACKGROUND Eight human catalytic phosphoinositide 3-kinase (PI3K) isoforms exist which are subdivided into three classes. While class I isoforms have been well-studied in cancer, little is known about the functions of class II PI3Ks.
Shalaby, Tarek, Guerreiro, A.S., Marinov, Marin, Koizumi, T., Arcaro, A., Depledge, Paul, Saghir, Nahid, Waterfield, Michael D, Laurentiis, A., Spertini, Olivier, Frei, K., Robson, A., Kaizawa, H., Höland, Katrin, Laurentiis, Angela D E, Boller, D., Fattet, S., Schweri-Olac, A., Kaizawa, Hiroyuki, Guerreiro, Ana S, Ohishi, Takahide, Höland, K., Grotzer, M.A., Ohishi, T., Marinov, M., Grotzer, Michael A, Delattre, O., Waterfield, M.D., Saghir, N., Hayakawa, Masahiko, Spertini, O., Fattet, Sarah, Boller, Danielle, Hayakawa, M., Arcaro, Alexandre, Laurentiis, Angela DE, Koizumi, Tomonobu, Delattre, Olivier, Schweri-Olac, Anelia, Frei, Karl, Shalaby, T., Depledge, P., Doepfner, K.T., Doepfner, Kathrin T, Robson, Anthony   +44 more
core   +2 more sources

GALLBLADDER NEUROENDOCRINE TUMOUR – AN ACCIDENTAL DISCOVERY

Archives of the Balkan Medical Union, 2021
Introduction. Primary neuroendocrine tumours of the gallbladder represent 0.2% of all neuroendocrine tumours. The diagnosis is incidental in most cases. Case report.
Gabriela ANGELESCU, Victor FLORESCU, Mihai T. ANGELESCU   +2 more
doaj   +1 more source